# A Study of Abatacept in Patients With Active Crohn's Disease

> **NCT00406653** · PHASE3 · TERMINATED · sponsor: **Bristol-Myers Squibb** · enrollment: 451 (actual)

## Conditions studied

- Crohn's Disease

## Interventions

- **DRUG:** abatacept
- **DRUG:** placebo
- **DRUG:** abatacept

## Key facts

- **NCT ID:** NCT00406653
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-12
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 451 (ACTUAL)
- **Why stopped:** Sponsor Decision
- **Last updated:** 2010-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00406653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00406653, "A Study of Abatacept in Patients With Active Crohn's Disease". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00406653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*